Eswatini vs Kazakhstan: New cases tested for RR-/MDR-TB
Eswatini
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Eswatini rank
1st
Kazakhstan rank
1st
New cases tested for RR-/MDR-TB over time
- Eswatini
- Kazakhstan
How they compare
Eswatini currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 2 times across 15 shared years of data; in 2007 it was Kazakhstan ahead.
Eswatini ranks 1st and Kazakhstan ranks 1st of 192 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eswatini | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.2% | 64.0% | 39.8% | Kazakhstan |
| 2010s | 67.7% | 98.3% | 30.6% | Kazakhstan |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Eswatini or Kazakhstan?
- Eswatini, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Eswatini and Kazakhstan?
- 0.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Kazakhstan?
- 15 years are reported by both, from 2007 to 2024.
- How do Eswatini and Kazakhstan rank globally for new cases tested for rr-/mdr-tb?
- Eswatini ranks 1st and Kazakhstan ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.